TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swetrade Pharmaceuticals AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,723
|
2,308
|
1,791 |
Financial expenses |
0
|
43
|
0 |
Earnings before taxes |
139
|
85
|
143 |
EBITDA |
136
|
39
|
143 |
Total assets |
1,975
|
1,996
|
1,712 |
Current assets |
1,849
|
1,878
|
1,547 |
Current liabilities |
376
|
631
|
381 |
Equity capital |
1,001
|
806
|
743 |
- share capital |
101
|
95
|
98 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.7%
|
40.4%
|
43.4% |
Turnover per employee |
1,362
|
1,154
|
896 |
Profit as a percentage of turnover |
5.1%
|
3.7%
|
8.0% |
Return on assets (ROA) |
7.0%
|
6.4%
|
8.4% |
Current ratio |
491.8%
|
297.6%
|
406.0% |
Return on equity (ROE) |
13.9%
|
10.5%
|
19.2% |
Change turnover |
251
|
571
|
-434 |
Change turnover % |
10%
|
33%
|
-20% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.